the thrombolysis in myocardial infarction ( timi ) study group is investigating whether percutaneous transluminal coronary angioplasty or intravenous beta-receptor blockers , or both , are useful adjuncts to recombinant tissue-type plasminogen activator ( rt-pa ) in the treatment of patients with acute myocardial infarction ( timi ii study ) .
C0032143
recombinant tissue
C0027051
timi